Literature DB >> 11489564

Management of posterior capsule rupture during phacoemulsification using the dry technique.

J Akura1, S Hatta, S Kaneda, M Ishihara, K Matsuura, A Tamai.   

Abstract

To manage posterior capsule rupture during phacoemulsification, we use a dry technique in which all procedures are performed without an irrigation/aspiration system. The dry technique is characterized by (1) continuous viscoelastic injection instead of fluid irrigation to maintain anterior chamber depth with the posterior capsule and vitreous located posteriorly and (2) static removal of most residual lens material by viscoexpression and/or manual small incision extracapsular cataract extraction without aspiration and dynamic water flow. In 16 cases of posterior capsule rupture managed using the dry technique, the residual nucleus and cortex were readily removed with minimum extension of the ruptured area and new vitreous loss. Although large amounts of viscoelastic material (mean 5.8 mL) were required, rapid and stable visual recovery was comparable to that in patients having uneventful surgery. The dry system is a safe and reliable technique for managing posterior capsule rupture during phacoemulsification.

Entities:  

Mesh:

Year:  2001        PMID: 11489564     DOI: 10.1016/s0886-3350(00)00838-5

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  3 in total

1.  Trimanual Anterior Vitrectomy: A Novel Technique to Manage Vitreous Loss during Phacoemulsification.

Authors:  Michael G Taggart; R Grant Morshedi; Balamurali K Ambati
Journal:  Case Rep Ophthalmol       Date:  2014-11-15

2.  Commentary: Scheimpflug imaging for evaluation of posterior lens capsule in pediatric traumatic cataract.

Authors:  Suresh K Pandey; Vidushi Sharma
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

3.  Scheimpflug imaging of pediatric posterior capsule rupture.

Authors:  Dilraj Singh Grewal; Rajeev Jain; Gagandeep Singh Brar; Satinder Pal Singh Grewal
Journal:  Indian J Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.